Patient-specific bacterial pathogens

Patient-specific bacterial pathogens refer to the unique microbial strains isolated from an individual patient that serve as the primary target for personalized antimicrobial interventions, such as phage therapy and autogenous vaccines [1, 4]. This approach is a cornerstone of precision medicine in infectious diseases, particularly for treating chronic or multi-drug resistant (MDR) infections where standard-of-care antibiotics have failed [2, 5]. By characterizing the specific isolate through genomic sequencing and susceptibility testing, clinicians can deploy tailored agents like lytic bacteriophages that specifically recognize and destroy the target bacteria while sparing the host's commensal microbiome [1, 3]. Autogenous vaccines further complement this by using inactivated samples of the patient's own pathogen to stimulate a bespoke immune response [6, 7]. The therapeutic success of targeting patient-specific pathogens depends on rapid diagnostic turnaround and the availability of diverse phage banks or rapid vaccine manufacturing platforms [4, 11]. Despite its potential, challenges remain regarding the evolution of bacterial resistance and the regulatory complexities of non-standardized, patient-specific biological products [4, 8].

Other names

Autogenous bacteriaPatient-derived bacterial isolatesClinical isolatesPersonalized bacterial targetsAutovaccine strains

The mechanism of action involves the use of tailored therapeutic agents, such as bacteriophages or autogenous vaccines, to specifically target and eliminate the unique bacterial strain isolated from a patient [1, 4]. Bacteriophages act by binding to specific surface receptors on the target bacteria, injecting their genetic material, and inducing lytic replication that results in bacterial cell death [2, 3]. Autogenous vaccines work by presenting inactivated whole-cell antigens from the patient's own isolate to the immune system, thereby stimulating a specific immune response, including opsonization and phagocytosis, against the infecting pathogen [6, 7].